Howard,
Reference the comment you made in your post #377: "I think QDEL is really starting to pull away from the pack of also-rans with their latest earnings report," and your last post #397.
Have you ever watched the old TV series Candid Camera. In one of the funniest episodes I ever saw, a guy stood in one of two bank teller lines. He noticed his line wasn't moving, so he stepped over to the other line. Sure enough, the line he moved to stopped, and the line he just left started moving. Well, he jockeyed back and forth between lines till his frustration built to the point where he looked like he was about ready to commit an OJ. Do you get the felling the market's taping another episode, and you're the star!
Seriously, Howard, if we could predict day to day market gyrations, we'd have made our fortunes a long time ago. I have no idea why Trinity went up yesterday and Quidel went down, nor do I think it's relevant to compare Trinity and Quidel. They've both got their own stories, and although they share some similarities, they're at quite different business development stages, and investors will buy there stock for quite different reasons.
If you're interested in Quidel, you should ask yourself some questions such as: Will Quidel's CLIA waved Strep and H.pylori tests continue to significantly increase sales? - If they will, you should buy. How to find out? - Like I suggested earlier, ask a P&G salesman, a few druggists in your area, or doctor questions to satisfy yourself the sales are strong. Asking readers on this thread why Triby or Quidel are up or down on any particular day really won't provide you much valuable information in my opinion. Peter Lynch made his investors money by staying "in line" with companies that he recognized would increase sales and earnings.
Mike |
